FNCT Biotech
↗Seongnam-si, South Korea
FNCT Biotech is a South Korean biotechnology company founded in 2021, dedicated to developing first-in-class antibody therapeutics for diseases with high unmet medical needs, particularly Idiopathic Pulmonary Fibrosis (IPF) and various cancers. The company leverages its proprietary platform to identify novel targets and develop human monoclonal antibodies that aim to reverse disease progression rather than merely slowing it down.
The company's core technology focuses on the Granulocyte Colony-Stimulating Factor 3 (CSF3) pathway, which they have identified as a 'super-regulator' of fibrosis. By targeting CSF3, FNCT Biotech aims to inhibit the overactivation of the TGF-β pathway, thereby preventing collagen deposition and tissue stiffening in the lungs. The company is currently transitioning from preclinical research to clinical-stage development following a successful Series A funding round.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Antibody therapeutics for fibrosis and oncology
SIZE & FINANCIALS
Employees:1-50
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$5.1M
Investors:BSK Investment, Industrial Bank of Korea (IBK), Meritz Securities, Premier Partners, Tech Incubator Program for Startup (TIPS)
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical (Preparing for Phase 1)
Modalities:Human Monoclonal Antibody (mAb)
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Inje University (Cardiovascular Precision Medicine research), Korea Institute of Radiological & Medical Sciences (KIRAMS) (Anti-cancer drug development)
COMPETITION
Position:Emerging
Competitors:Bridge Biotherapeutics, Daewoong Pharmaceutical, Roche (Pirfenidone), Boehringer Ingelheim (Nintedanib)
LEADERSHIP
Key Executives:
Su-Jae Lee - CEO & CTO
Young-Woo Jin - Senior Managing Director & CBO/CSO
Min-Jung Kim - Senior Managing Director & COO
Scientific Founders:Su-Jae Lee
LINKS
Website:fnctbiotech.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with FNCT Biotech. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.